Walleye Trading
PTCT icon

Walleye Trading’s PTC Therapeutics PTCT Stock Holding History

Walleye Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,926
Closed -$1.21M – 4584
2025
Q4 		$1.21M Buy
15,926
+4,850
+44% +$352K ﹤0.01% 2234
2025
Q3 		$680K Buy
+11,076
New +$577K ﹤0.01% 2527
2023
Q2 		– Sell
-5,426
Closed -$263K – 5104
2023
Q1 		$263K Sell
5,426
-287
-5% -$13.1K ﹤0.01% 3314
2022
Q4 		$218K Buy
+5,713
New +$237K ﹤0.01% 3503
2021
Q4 		– Sell
-12,841
Closed -$478K – 5761
2021
Q3 		$478K Buy
+12,841
New +$527K ﹤0.01% 2963
2020
Q2 		– Sell
-2,453
Closed -$121K – 4536
2020
Q1 		$109K Sell
2,453
-33
-1% -$1.66K ﹤0.01% 3050
2019
Q4 		$119K Buy
+2,486
New +$106K ﹤0.01% 3469
2019
Q3 		– Sell
-1,677
Closed -$73K – 4355
2019
Q2 		$75K Buy
+1,677
New +$66.2K ﹤0.01% 3415
2017
Q3 		– Sell
-100
Closed -$2 – 4504
2017
Q2 		$2 Sell
100
-1,300
-93% -$17.5K ﹤0.01% 4411
2017
Q1 		$14 Buy
+1,400
New +$16.9K ﹤0.01% 4248
2015
Q2 		– Sell
-7,201
Closed -$438K – 5082
2015
Q1 		$438K Buy
+7,201
New +$439K ﹤0.01% 1590

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Walleye Trading's PTCT Position: Q1 2026 in Review

Walleye Trading sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 15,926 shares — an estimated $1.21M sold.

Walleye Trading first reported a position in PTCT in Q1 2015 and held it in 11 quarters. The position peaked at $1.21M in Q4 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Walleye Trading reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 15,926 PTC Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Walleye Trading first reported a position in PTC Therapeutics in Q1 2015 and held it in 11 quarters.
  • Walleye Trading's PTC Therapeutics position peaked at $1.21M in Q4 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.